Spero Therapeutics Inc (SPRO) stock news · rev $66.8M
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
This SPRO news page leads with what Spero Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for SPRO yet. We will not pad this page with generic market recap.
Latest reported SPRO revenue for 2025-12-31 was $66.8M. Net income was $8.6M. Revenue was up 39.2% from 2024-12-31 to 2025-12-31. SPRO currently screens at market cap $149.5M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SPRO stock page; for the tape open the quote page.
SPRO stock news FAQ
What are SPRO's latest revenue and net income?
Latest cached Spero Therapeutics Inc (SPRO) revenue for Dec 31, 2025 was $66.8M. Net income was $8.6M. Statements: https://lician.com/financials/spro
How did SPRO revenue change from the prior cached period?
Cached Spero Therapeutics Inc (SPRO) revenue was up 39.2% from $48.0M (Dec 31, 2024) to $66.8M (Dec 31, 2025). Statements: https://lician.com/financials/spro
What is SPRO's market cap?
Spero Therapeutics Inc (SPRO) market cap is $149.5M on the latest cached fundamentals snapshot.
What kind of company is SPRO?
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Where is SPRO stock news listed?
Cached stock news for Spero Therapeutics Inc (SPRO) is listed at https://lician.com/news/spro. Filings: https://lician.com/sec/spro
Not investment advice.